retatrutide triple agonist gip glp-1 glucagon phase 2 obesity #retatrutide (GLP-1, GIP, Glucagon) achieved 22-24% weight loss at 48 weeks with a similar tolerability profile to #tirzepatide. @lillypad is moving forward with 3 trials for There's a new drug going
Pay in 4 interest-free payments of $7.24 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30


:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)












02105-1/asset/8468e457-0c7f-4e4c-9b6d-2202dbefa9cb/main.assets/gr1_lrg.jpg)











